Search company, investor...

Adastra Pharmaceuticals

adastrarx.com

Founded Year

2005

Stage

Series E - II | Alive

Total Raised

$90.65M

Last Raised

$1.4M | 3 yrs ago

About Adastra Pharmaceuticals

Adastra Pharmaceuticals is a private, clinical-stage biopharmaceutical company committed to providing responsible solutions to advance patient care in oncology. Its vision is to identify, develop, and deliver to patients important new therapies for diseases with significant unmet needs. This commitment is epitomized by its lead clinical candidate, zotiraciclib, which is initially being developed for the treatment of high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG), two forms of brain cancer characterized by Myc overexpression. Adastra possesses a rich history of institutional and academic collaboration, including ongoing clinical research programs with the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC).

Headquarters Location

202 Carnegie Center Suite 104

Princeton, New Jersey, 08540,

United States

760-208-6900

Missing: Adastra Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Adastra Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Adastra Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Adastra Pharmaceuticals is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Adastra Pharmaceuticals Patents

Adastra Pharmaceuticals has filed 4 patents.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Transcription factors
  • Acute myeloid leukemia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2020

11/16/2021

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Grant

Application Date

8/12/2020

Grant Date

11/16/2021

Title

Related Topics

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Status

Grant

Latest Adastra Pharmaceuticals News

Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals

Oct 6, 2021

Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"

Adastra Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Adastra Pharmaceuticals founded?

    Adastra Pharmaceuticals was founded in 2005.

  • Where is Adastra Pharmaceuticals's headquarters?

    Adastra Pharmaceuticals's headquarters is located at 202 Carnegie Center, Princeton.

  • What is Adastra Pharmaceuticals's latest funding round?

    Adastra Pharmaceuticals's latest funding round is Series E - II.

  • How much did Adastra Pharmaceuticals raise?

    Adastra Pharmaceuticals raised a total of $90.65M.

  • Who are the investors of Adastra Pharmaceuticals?

    Investors of Adastra Pharmaceuticals include Domain Associates, ProQuest Investments, Mitsubishi Corporation, Rusnano, Morgenthaler Ventures and 7 more.

  • Who are Adastra Pharmaceuticals's competitors?

    Competitors of Adastra Pharmaceuticals include Viracta Therapeutics, Bexion Pharmaceuticals, Vaccinex, Solasia Pharma, Kolltan Pharmaceuticals, Reata Pharmaceuticals, Alligator Bioscience, Nps Pharmaceuticals, Questcor Pharmaceuticals, Acton Pharmaceuticals and 13 more.

Compare Adastra Pharmaceuticals to Competitors

A
Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

K
Kanisa Pharmaceuticals

Kanisa Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of therapeutics in the field of oncology.

N
Nautilus Neuroscience

Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders. In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA¯¿½ (diclofenac potassium for oral solution).

VGXI Logo
VGXI

VGXI is a contract manufacturer of plasmid DNA. The company delivers flexibility, experience, reliability, and value to clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.